Profile data is unavailable for this security.
About the company
Hanshang Group Co Ltd is a China-based company mainly engaged in the research, development, production and sales of pharmaceuticals and medical devices, as well as commercial operations and exhibition operations. The Company operates three segments. The Commercial Operations segment is mainly engaged in the commercial operation and management of shopping malls and specialized markets. The Exhibition Operations segment is mainly engaged in the provision of clients with exhibition operation and related services, including the organization, planning, promotion and business development of exhibitions, as well as booth construction, exhibition advertising, plaza event organization, conference services, exhibition equipment rental and parking services. The Pharmaceuticals and Medical Devices segment is mainly engaged in the research, development, production and sales of pharmaceuticals and medical devices in the fields of digestive system, respiratory system and anti-infectives.
- Revenue in CNY (TTM)1.04bn
- Net income in CNY-7.75m
- Incorporated1990
- Employees2.24k
- LocationHanshang Group Co LtdNo. 134, Hanyang AvenueWUHAN 430050ChinaCHN
- Phone+86 2 768849191
- Fax+86 2 784842384
- Websitehttps://www.whhsg.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hainan Huluwa Pharmaceutical Grop Co Ltd | 902.48m | -369.56m | 2.71bn | 2.10k | -- | 3.93 | -- | 3.00 | -0.9236 | -0.9236 | 2.26 | 1.72 | 0.3055 | 1.74 | 1.60 | 429,141.60 | -12.36 | 0.2178 | -22.13 | 0.3739 | 31.53 | 54.80 | -40.47 | 0.3213 | 0.5566 | -6.97 | 0.6414 | 700.10 | -21.26 | 1.60 | -2,629.23 | -- | 21.75 | -- |
| Zhejiang Shapuaisi Pharmaceutical Co Ltd | 475.19m | -65.05m | 2.84bn | 1.33k | -- | 1.76 | -- | 5.98 | -0.1796 | -0.1796 | 1.27 | 4.31 | 0.2236 | 2.35 | 14.31 | 357,822.00 | -3.08 | -2.12 | -3.66 | -2.49 | 50.11 | 55.38 | -13.78 | -7.33 | 0.8289 | -0.9506 | 0.1587 | -- | -24.96 | -1.27 | -585.85 | -- | 44.50 | -- |
| Shanghai Serum Bio-Technology Co Ltd | 196.76m | 45.55m | 2.93bn | 326.00 | 64.21 | 2.60 | -- | 14.87 | 0.4209 | 0.4209 | 1.82 | 10.40 | 0.1706 | 1.22 | 3.20 | 603,567.30 | 3.95 | 7.64 | 4.04 | 7.87 | 76.68 | 78.94 | 23.15 | 30.08 | 27.50 | -- | 0.0035 | 77.34 | 2.51 | 0.7147 | 14.23 | -7.60 | 18.77 | -- |
| Hanshang Group Co Ltd | 1.04bn | -7.75m | 2.97bn | 2.24k | -- | 1.78 | -- | 2.86 | -0.0263 | -0.0263 | 3.51 | 5.66 | 0.2992 | 2.45 | 8.58 | 463,254.10 | -0.5073 | 1.38 | -0.911 | 2.59 | 44.80 | 61.66 | -1.70 | 3.79 | 0.3006 | -0.0194 | 0.300 | 17.52 | -15.41 | 0.3108 | -123.83 | -- | 4.52 | -- |
| Ginwa Enterprise Group Inc | 550.44m | 78.32m | 2.98bn | 588.00 | 37.04 | 1.88 | -- | 5.42 | 0.2157 | 0.2157 | 1.54 | 4.24 | 0.2885 | 4.56 | 4.97 | 936,120.60 | 4.04 | 0.839 | 4.86 | 0.9762 | 76.30 | 75.14 | 14.00 | 2.83 | 1.84 | -- | 0.0561 | 52.12 | 3.55 | -4.95 | 273.96 | 23.56 | 28.32 | 0.00 |
| Novoprotein Scientific Inc | 147.33m | -65.02m | 3.09bn | 566.00 | -- | 1.48 | -- | 21.00 | -0.9301 | -0.9301 | 2.10 | 29.82 | 0.0664 | 0.7531 | 2.20 | 260,302.10 | -2.93 | 4.36 | -3.02 | 4.58 | 62.01 | 74.11 | -44.13 | 26.35 | 24.75 | -- | 0.0227 | 24.96 | -16.73 | 28.80 | -523.69 | -- | 166.98 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 1.09m | 0.48% |
| Gfund Management Co., Ltd.as of 30 Jun 2025 | 230.30k | 0.10% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 108.50k | 0.05% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 2025 | 98.60k | 0.04% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2025 | 36.90k | 0.02% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 36.60k | 0.02% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 13.30k | 0.01% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 4.20k | 0.00% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 1.30k | 0.00% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 500.00 | 0.00% |
